Vivos Therapeutics (VVOS) Change in Receivables (2020 - 2026)
Vivos Therapeutics (VVOS) reported Change in Receivables of $188000.0 for Q1 2026, down 34.72% year-over-year from $288000.0 in Q1 2025, and up 134.0% quarter-over-quarter from -$553000.0 in Q4 2025.
Vivos Therapeutics (VVOS) Change in Receivables (2020 - 2026) Analysis & Trends
Vivos Therapeutics (VVOS) has 7 years of Change in Receivables data on file, last reported at $188000.0 in Q1 2026.
- Change in Receivables for Q1 2026 came in at $188000.0, down 34.72% year-over-year; the trailing twelve-month figure through Mar 2026 was $117000.0 (down 39.06% YoY), and the FY2025 annual result was $217000.0, down 4.82% from the prior year.
- Change in Receivables climbed to $188000.0 in Q1 2026 per VVOS's latest filing, from -$553000.0 in the prior quarter.
- Over five years, Change in Receivables peaked at $501000.0 in Q3 2025 and troughed at -$553000.0 in Q4 2025.
- A 5-year average of -$21647.1 and a median of -$24000.0 in 2024 frame the typical range for Change in Receivables.
- The sharpest annual moves came in 2024 and 2025: Change in Receivables plunged 2283.33% in 2024, then surged 749.15% in 2025.
- A 5-year view of Change in Receivables shows it stood at -$409000.0 in 2022, then jumped by 93.64% to -$26000.0 in 2023, then increased by 7.69% to -$24000.0 in 2024, then sank by 2204.17% to -$553000.0 in 2025, then surged by 134.0% to $188000.0 in 2026.
- Business Quant data shows VVOS's Change in Receivables at $188000.0 in Q1 2026, -$553000.0 in Q4 2025, and $501000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 42.00 Mn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | -444.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | -13.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 117.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 117.90 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | -124.60 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | -141.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 123.50 Mn |
| 10 | Vivos Therapeutics | 7.39 Mn | 5.16 Mn | 3.06 Mn | 188,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 188,000.00 |
| Mar 31, 2026 | 188,000.00 |
| Dec 31, 2025 | -553,000.00 |
| Dec 31, 2025 | -553,000.00 |
| Sep 30, 2025 | 501,000.00 |
| Sep 30, 2025 | 501,000.00 |
| Jun 30, 2025 | -19,000.00 |
| Jun 30, 2025 | -19,000.00 |
| Mar 31, 2025 | 288,000.00 |
| Mar 31, 2025 | 288,000.00 |
| Dec 31, 2024 | -24,000.00 |
| Dec 31, 2024 | -24,000.00 |
| Sep 30, 2024 | 59,000.00 |
| Sep 30, 2024 | 59,000.00 |
| Jun 30, 2024 | -131,000.00 |
| Jun 30, 2024 | -131,000.00 |
| Mar 31, 2024 | 324,000.00 |
| Mar 31, 2024 | 324,000.00 |
| Dec 31, 2023 | -26,000.00 |
| Dec 31, 2023 | -26,000.00 |